臨床試験用医薬品の世界市場レポート 2025年

臨床試験用医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で40億3,000万米ドルに成長します。予測期間の成長は、臨床試験の世界化、細胞・遺伝子治療試験の拡大、患者中心の臨床試験への注目の高まり、臨床試験における生物製剤やバイオシミラー医薬品の増加、バーチャル臨床試験や分散型臨床試験の台頭などに起因すると考えられます。予測期間における主な動向としては、人工知能（AI）と予測分析の統合、3Dプリンティング、臨床試験供給管理における持続可能性と環境配慮への注目の高まり、バイオ医薬品・製薬企業による研究開発投資の拡大、ブロックチェーン技術の進歩などが挙げられます。

臨床試験用医薬品市場は、臨床試験の登録件数の増加により、大幅な成長が見込まれています。これらの臨床試験は、新しい治療、介入、診断方法の安全性と有効性を評価するために不可欠であり、医薬品や医療機器を含むさまざまな供給品に依存しています。2023年5月、ClinicalTrials.govは、米国と221カ国で2022年の399,499件に対し、437,533件の臨床試験が登録され、顕著な増加を報告しています。このような臨床試験の登録件数の急増は、臨床試験用医薬品市場の拡大を後押しする重要な要因であり、臨床試験の成功、正確なデータ収集、患者の安全を確保する上で極めて重要です。

臨床試験用医薬品市場は、老年人口の拡大に後押しされ、大きな成長が見込まれています。老年人口」とは、65歳以上の高齢者を指し、多くの場合、複数の健康状態を抱えています。この人口動態の変化により、加齢関連疾患に焦点を当てた研究開発を支援するための多様で専門的な治験薬の需要が高まっています。2022年10月現在、世界保健機関（WHO）の報告書によると、2030年までに世界の6人に1人が60歳以上になると予測されています。2050年には、その数は21億人に達すると予想されています。その結果、老人人口の増加が臨床試験用医薬品市場の成長を牽引する極めて重要な役割を果たすことになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界臨床試験用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の臨床試験用医薬品市場：成長率分析
• 世界の臨床試験用医薬品市場の実績：規模と成長, 2019-2024
• 世界の臨床試験用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界臨床試験用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の臨床試験用医薬品市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 物流と流通
• 保管と保持
• サプライチェーンマネジメント
• 包装、ラベル付け、ブラインド化
• 製造業
• 比較ソーシング
• 世界の臨床試験用医薬品市場臨床段階別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV
• 世界の臨床試験用医薬品市場治療目的による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 中枢神経系（CNS）
• 心臓血管
• 感染症
• 代謝障害
• その他の治療用途
• 世界の臨床試験用医薬品市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬・バイオテクノロジー企業
• 調査業務受託機関（CRO）
• 医療機器企業
• 世界の臨床試験用医薬品市場、物流と流通のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 交通機関
• 在庫管理
• 温度管理配送
• 通関
• 世界の臨床試験用医薬品市場、ストレージと保持のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 短期保管
• 長期保管
• 制御環境ストレージ
• 世界の臨床試験用医薬品市場、サプライチェーン管理のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 計画と予測
• サプライヤー管理
• リスク管理
• コンプライアンス管理
• 世界の臨床試験用医薬品市場、包装、ラベル、ブラインドの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一次包装
• 二次包装
• ラベルデザインと印刷
• ブラインド技術
• 世界の臨床試験用医薬品市場、製造業のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品有効成分（API）製造
• 処方開発
• バッチ生産
• 世界の臨床試験用医薬品市場、比較ソーシングのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 参照製品の調達
• 品質管理と保証
• 比較対象者の規制遵守

第7章 地域別・国別分析

• 世界の臨床試験用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の臨床試験用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臨床試験用医薬品市場：競合情勢
• 臨床試験用医薬品市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Parexel International Corporation Overview, Products and Services, Strategy and Financial Analysis
  • ICON PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Catalent Inc.
• Intertek Group PLC
• Recipharm AB
• World Courier
• Almac Group Ltd.
• Piramal Pharma Solutions
• Clinigen Group PLC
• Movianto GmbH
• Marken Limited
• PCI Pharma Services
• Rubicon Research Private Limited
• Bionical Ltd.
• Durbin PLC
• SIRO Clinpharm Pvt. Ltd.
• Biocair International Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 臨床試験用医薬品市場2029：新たな機会を提供する国
• 臨床試験用医薬品市場2029：新たな機会を提供するセグメント
• 臨床試験用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Clinical trial supplies encompass materials, products, and equipment pivotal for the smooth conduct of clinical trials. They are instrumental in facilitating testing and evaluation processes.

Essential services related to clinical trial supplies involve logistics and distribution, storage and retention, supply chain management, packaging, labeling, blinding manufacturing, and comparator sourcing. Logistics and distribution manage the movement of trial supplies from manufacturing facilities to trial sites, ensuring prompt availability and efficient delivery. These supplies are crucial across various clinical phases (Phase I to Phase IV) for treating conditions such as oncology, CNS disorders, cardiovascular ailments, infectious diseases, metabolic disorders, among others. End users include pharmaceutical and biotech companies, contract research organizations (CROs), and medical device firms.

The clinical trial supplies research report is one of a series of new reports from The Business Research Company that provides clinical trial supplies market statistics, including the clinical trial supplies industry's global market size, regional shares, competitors with a clinical trial supplies market share, detailed clinical trial supplies market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supplies industry. This clinical trial supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical trial supplies market size has grown strongly in recent years. It will grow from $2.68 billion in 2024 to $2.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, stringent regulatory requirements, increasing demand for clinical trials to develop new treatments, increasing complexity of clinical trials

The clinical trial supplies market size is expected to see strong growth in the next few years. It will grow to $4.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to globalization of clinical trials, expansion of cell and gene therapy trials, increased focus on patient-centric trials, growing number of biologics and biosimilar drugs in trials, rise of virtual and decentralized trials. Major trends in the forecast period include integration of artificial intelligence (AI) and predictive analytics, 3D printing, increasing focus on sustainability and eco-friendliness in clinical trial supply management, growing R&D investments by biopharmaceutical and pharmaceutical companies, blockchain technology advancements.

The clinical trial supplies market is poised for substantial growth, driven by the escalating number of registered clinical trials. These trials, essential for assessing the safety and efficacy of new medical treatments, interventions, and diagnostic procedures, rely on a range of supplies, including pharmaceuticals and medical devices. To illustrate, in May 2023, ClinicalTrials.gov reported a notable increase, with 437,533 registered clinical trials compared to 399,499 in 2022 across the United States and 221 countries. This surge in clinical trial registrations is a key factor fueling the expansion of the clinical trial supplies market, crucial for ensuring successful trials, accurate data collection, and patient safety.

The clinical trial supplies market is expected to experience significant growth, propelled by the expanding geriatric population. The term 'geriatric population' refers to individuals aged 65 and older, often dealing with multiple health conditions. This demographic shift creates a heightened demand for diverse and specialized trial supplies to support research and development efforts focused on age-related diseases. As of October 2022, a report from the World Health Organization projects that by 2030, one out of every six individuals globally will be 60 years old or older. By 2050, the number is expected to reach 2.1 billion. Consequently, the growing geriatric population plays a pivotal role in driving the clinical trial supplies market's growth.

A prominent trend shaping the landscape of the clinical trial supplies market is the adoption of advanced real-world evidence platforms. Leading companies in this market are embracing innovative technologies to revolutionize healthcare decision-making, drug development, and patient care. This strategic move involves harnessing real-world data to generate evidence-based insights. As an illustration, in April 2023, Komodo Health, a US-based healthcare technology company, introduced MapEnhance-an integrated real-world evidence technology platform. This platform, incorporating a network of specialty data partners, provides customers with a comprehensive perspective on clinical events and patient populations. MapEnhance includes precision molecular diagnostics, standard laboratory diagnostics, and electronic medical records, offering unparalleled insights for various therapeutic areas and hospital settings.

Major players in the clinical trial supplies market are actively investing in cutting-edge technologies, such as clinical development platforms, to broaden their customer base, drive sales, and enhance revenue. A clinical development platform serves as an integrated system or software facilitating the planning, management, execution, and monitoring of clinical trials and research studies. For instance, in June 2022, ZS Associates, a US-based management consulting and technology firm, launched the ZAIDYN Clinical Development platform. This platform stands out for its ability to break down silos in clinical trial design, overcome enrollment and engagement obstacles, and expedite product delivery to patients. ZAIDYN facilitates seamless global team collaboration, connecting products, processes, applications, algorithms, and data assets to provide potent insights influencing clinical research. Its compatibility with existing IT systems enhances efficiency and connectivity, reducing costs and empowering life sciences companies of all sizes to innovate and thrive in the evolving global healthcare ecosystem.

In May 2024, Myonex, a pharmaceutical company based in the US, acquired Creapharm's pharmaceutical services for an undisclosed amount. Following this acquisition, Creapharm's capabilities in clinical packaging, distribution, commercial packaging, and bioservices will operate under the name Creapharm, a Myonex company. This merger enhances flexibility and strengthens service offerings for pharmaceutical and biotech companies at both clinical and commercial stages, including those involved with Advanced Therapies. Creapharm is a manufacturer of clinical trial supplies based in France.

Major companies operating in the clinical trial supplies market include Thermo Fisher Scientific Inc., IQVIA, Eurofins Scientific SE, Parexel International Corporation, ICON PLC, Catalent Inc., Intertek Group PLC, Recipharm AB, World Courier, Almac Group Ltd., Piramal Pharma Solutions, Clinigen Group PLC, Movianto GmbH, Marken Limited, PCI Pharma Services, Rubicon Research Private Limited, Bionical Ltd., Durbin PLC, SIRO Clinpharm Pvt. Ltd., Biocair International Ltd., Ancillare LP., Myonex, Klifo A/S, Alium Medical Limited, ADAllen Pharma, Sharp Services LLC

North America was the largest region in the clinical trial supplies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical trial supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial supplies market consists of revenues earned by entities by providing quality control, regulatory compliance, and return and destruction management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial supplies market also includes sales of investigational products, comparator products, and clinical trial kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Supplies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial supplies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial supplies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial supplies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Services: Logistics And Distribution; Storage And Retention; Supply Chain Management; Packaging, Labeling, And Blinding; Manufacturing; Comparator Sourcing
• 2) By Clinical Phases: Phase I; Phase II; Phase III; Phase IV
• 3) By Therapeutic Use: Oncology; Central Nervous System (CNS); Cardiovascular; Infectious Disease; Metabolic Disorders; Other Therapeutic Uses
• 4) By End User: Pharmaceutical And Biotech companies; Contract Research Organization (CRO); Medical Device Companies
• Subsegments:
• 1) By Logistics And Distribution: Transportation; Inventory Management; Temperature-Controlled Shipping; Customs Clearance
• 2) By Storage And Retention: Short-term Storage; Long-term Storage; Controlled Environment Storage
• 3) By Supply Chain Management: Planning And Forecasting; Supplier Management; Risk Management; Compliance Management
• 4) By Packaging, Labeling, And Blinding: Primary Packaging; Secondary Packaging; Label Design And Printing; Blinding Techniques
• 5) By Manufacturing: Active Pharmaceutical Ingredient (API) Production; Formulation Development; Batch Production
• 6) By Comparator Sourcing: Sourcing Of Reference Products; Quality Control And Assurance; Regulatory Compliance For Comparators
• Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA; Eurofins Scientific SE; Parexel International Corporation; ICON PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Supplies Market Characteristics

3. Clinical Trial Supplies Market Trends And Strategies

4. Clinical Trial Supplies Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Clinical Trial Supplies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Trial Supplies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Trial Supplies Market Growth Rate Analysis
• 5.4. Global Clinical Trial Supplies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Trial Supplies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Trial Supplies Total Addressable Market (TAM)

6. Clinical Trial Supplies Market Segmentation

• 6.1. Global Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Logistics and Distribution
• Storage and Retention
• Supply Chain Management
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• 6.2. Global Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.3. Global Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Central Nervous System (CNS)
• Cardiovascular
• Infectious Disease
• Metabolic Disorders
• Other Therapeutic Uses
• 6.4. Global Clinical Trial Supplies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical and Biotech Companies
• Contract Research Organization (CRO)
• Medical Device Companies
• 6.5. Global Clinical Trial Supplies Market, Sub-Segmentation Of Logistics And Distribution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transportation
• Inventory Management
• Temperature-Controlled Shipping
• Customs Clearance
• 6.6. Global Clinical Trial Supplies Market, Sub-Segmentation Of Storage And Retention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short-term Storage
• Long-term Storage
• Controlled Environment Storage
• 6.7. Global Clinical Trial Supplies Market, Sub-Segmentation Of Supply Chain Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Planning And Forecasting
• Supplier Management
• Risk Management
• Compliance Management
• 6.8. Global Clinical Trial Supplies Market, Sub-Segmentation Of Packaging, Labeling, And Blinding, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Packaging
• Secondary Packaging
• Label Design And Printing
• Blinding Techniques
• 6.9. Global Clinical Trial Supplies Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Pharmaceutical Ingredient (API) Production
• Formulation Development
• Batch Production
• 6.10. Global Clinical Trial Supplies Market, Sub-Segmentation Of Comparator Sourcing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sourcing Of Reference Products
• Quality Control And Assurance
• Regulatory Compliance For Comparators

7. Clinical Trial Supplies Market Regional And Country Analysis

• 7.1. Global Clinical Trial Supplies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Trial Supplies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Trial Supplies Market

• 8.1. Asia-Pacific Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Trial Supplies Market

• 9.1. China Clinical Trial Supplies Market Overview
• 9.2. China Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Trial Supplies Market

• 10.1. India Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Trial Supplies Market

• 11.1. Japan Clinical Trial Supplies Market Overview
• 11.2. Japan Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Trial Supplies Market

• 12.1. Australia Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Trial Supplies Market

• 13.1. Indonesia Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Trial Supplies Market

• 14.1. South Korea Clinical Trial Supplies Market Overview
• 14.2. South Korea Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Trial Supplies Market

• 15.1. Western Europe Clinical Trial Supplies Market Overview
• 15.2. Western Europe Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Trial Supplies Market

• 16.1. UK Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Trial Supplies Market

• 17.1. Germany Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Trial Supplies Market

• 18.1. France Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Trial Supplies Market

• 19.1. Italy Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Trial Supplies Market

• 20.1. Spain Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Trial Supplies Market

• 21.1. Eastern Europe Clinical Trial Supplies Market Overview
• 21.2. Eastern Europe Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Trial Supplies Market

• 22.1. Russia Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Trial Supplies Market

• 23.1. North America Clinical Trial Supplies Market Overview
• 23.2. North America Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Trial Supplies Market

• 24.1. USA Clinical Trial Supplies Market Overview
• 24.2. USA Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Trial Supplies Market

• 25.1. Canada Clinical Trial Supplies Market Overview
• 25.2. Canada Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Trial Supplies Market

• 26.1. South America Clinical Trial Supplies Market Overview
• 26.2. South America Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Trial Supplies Market

• 27.1. Brazil Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Trial Supplies Market

• 28.1. Middle East Clinical Trial Supplies Market Overview
• 28.2. Middle East Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Trial Supplies Market

• 29.1. Africa Clinical Trial Supplies Market Overview
• 29.2. Africa Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Trial Supplies Market Competitive Landscape And Company Profiles

• 30.1. Clinical Trial Supplies Market Competitive Landscape
• 30.2. Clinical Trial Supplies Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Parexel International Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ICON PLC Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Trial Supplies Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Intertek Group PLC
• 31.3. Recipharm AB
• 31.4. World Courier
• 31.5. Almac Group Ltd.
• 31.6. Piramal Pharma Solutions
• 31.7. Clinigen Group PLC
• 31.8. Movianto GmbH
• 31.9. Marken Limited
• 31.10. PCI Pharma Services
• 31.11. Rubicon Research Private Limited
• 31.12. Bionical Ltd.
• 31.13. Durbin PLC
• 31.14. SIRO Clinpharm Pvt. Ltd.
• 31.15. Biocair International Ltd.

32. Global Clinical Trial Supplies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Trial Supplies Market

34. Recent Developments In The Clinical Trial Supplies Market

35. Clinical Trial Supplies Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Trial Supplies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Trial Supplies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Trial Supplies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer